Aims To explore the association between the use of glycaemic technologies and person‐
reported outcomes (PROs) in adults with type 1 diabetes (T1D). Methods We included T1D …

Diabetes is a common metabolic complication of pregnancy and affected women fall into two
subgroups: women with pre-existing diabetes and those with gestational diabetes mellitus …

With randomised trial data confirming that continuous glucose monitoring (CGM) is
associated with improvements in maternal glucose control and neonatal health outcomes …

The American Diabetes Association (ADA)“Standards of Care in Diabetes” includes the
ADA's current clinical practice recommendations and is intended to provide the components …

OBJECTIVE Continuous glucose monitoring (CGM) improves maternal glycemic control and
neonatal outcomes in type 1 diabetes pregnancies compared with self-monitoring of blood …

Aim Diabetes is associated with a high risk of adverse pregnancy outcomes. Optimal
glycaemic control is fundamental and is traditionally monitored with self‐measured glucose …

Background Insulin degludec (degludec) is a second-generation basal insulin with an
improved pharmacokinetic–pharmacodynamic profile compared with first-generation basal …

This is the full version of the Australasian Diabetes in Pregnancy Society (ADIPS) 2020
guideline for pre‐existing diabetes and pregnancy. The guideline encompasses the …

OBJECTIVE To compare glycemic control, quality of life, and pregnancy outcomes of women
using insulin pumps and multiple daily injection therapy (MDI) during the Continuous …

Gestational diabetes (GDM) is hyperglycemia that is recognized for the first time during
pregnancy. GDM is associated with a wide range of short-and long-term adverse health …